Pfizer Systematic Deployment in USA
By Craig Paardekooper
If the separate companies were deploying high toxicity batches systematically, then the patterns of deployment could be confused and clouded by mixing data for all of the companies.
So, instead of combining all of the VAERS data for Moderna, and for Pfizer, I decided to separate them out.
In addition to this, these clusters of toxic batches are separated by clear periods of harmless batches – then the sudden appearance of another cluster.